• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Food & Drug Administration (FDA)

Aptar wins FDA contract to study low global warning potential metered dose inhalers

December 4, 2023 By Sean Whooley

Aptar Pharma inhaler

Aptar Pharma announced today that it entered into a contract with the FDA to work on low global warming potential (low-GWP) inhalers. The FDA enlisted Aptar to study the challenges of developing low-GWP propellant metered dose inhalers (MDIs). The Crystal Lake, Illinois-based company expects its study to help define the potential target product profile of […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Funding Roundup Tagged With: aptarpharma, FDA

Baxter issues Novum IQ infusion pump warning

December 1, 2023 By Sean Whooley

Baxter Novum IQ Syringe Pump

Correction: the original version of this article identified this as another recall for Novum IQ. Baxter issued a notification related to a Nov. 15 recall, not a notification for a separate recall. This story has been updated. Baxter (NYSE:BAX) issued an urgent medical device correction notice regarding its Novum IQ syringe infusion pump. A few […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls, Technology Tagged With: Baxter, FDA

Eitan Medical’s Sapphire infusion pump recall is Class I

December 1, 2023 By Sean Whooley

Eitan Medical Sapphire Multi-Therapy infusion pump

The FDA determined that the recall of certain Eitan Medical Sapphire infusion pumps is Class I, the most serious kind. Netanya, Israel-based Eitan recalled certain Sapphire pumps running software version Rev 16.10. The recall includes the Sapphire multi-therapy pump, the Sapphire Epidural pump and the Sapphire Plus pump. Eitan initiated the recall on Sept. 11, […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls, Technology Tagged With: Eitan Medical, FDA

FDA warning doesn’t affect Embecta syringes, company says

December 1, 2023 By Sean Whooley

Embecta BD U-500 insulin syringe

Embecta (Nasdaq:EMBC) says an FDA safety communication regarding certain plastic syringes has no impact on its own products. The FDA yesterday warned of the potential for device failures with plastic syringes manufactured in China. Failures could include leaks, breakage and other problems. The agency said it received information about quality issues associated with several Chinese […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: embecta

B. Braun infusion pump battery recall is Class I after one reported death

November 17, 2023 By Sean Whooley

B. Braun Infusomat Space large-volume infusion pump

The FDA labeled a recall of B. Braun Medical infusion pump battery packs Class I, the most serious kind. B. Braun’s recall is a correction, not a product removal, affecting the battery pack for its Infusomat Space large-volume pump. It affects both wireless and non-wireless batteries, model numbers 8713051U and 8713052U. According to an FDA […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance Tagged With: B. Braun, B. Braun Medical, FDA

Baxter recalls some syringe pumps due to underdosing risk

November 16, 2023 By Sean Whooley

Baxter Novum IQ Infusion (BD alleges patent infringement against the system)

The FDA determined that the recall of the Baxter (NYSE:BAX) Novum IQ syringe pump is Class 1, the most serious kind. Baxter designed its Novum IQ syringe pump as an infusion pump to deliver fluids into a patient’s body in a controlled manner. The device is suitable for patient care in hospitals and outpatient facilities […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls, Technology Tagged With: Baxter, FDA

FDA issues warning about over-the-counter eye drops

October 30, 2023 By Sean Whooley

FDA-logo-new

The FDA issued a notice warning consumers about 26 over-the-counter eye drop products that could result in eye infections. In its notice, the FDA instructed consumers not to purchase and to immediately stop using these products. Using those eye drops could lead to the risk of infections that could result in partial vision loss or […]

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Optical/Ophthalmic, Recalls, Regulatory/Compliance Tagged With: Cardinal Health, CVS Health, FDA

FDA clears iPhone app for the Insulet Omnipod 5

October 23, 2023 By Sean Whooley

Insulet Omnipod 5 Dexcom G6

Insulet (Nasdaq:PODD) announced today that the FDA granted 510(k) clearance for its Omnipod 5 App for iPhone. Clearance makes Insulet the only company offering a tubeless, automated insulin delivery (AID) system with full control from a compatible Android and iOS smartphone. The company first launched the system, compatible with Android devices, in August 2022. Insulet […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Regulatory/Compliance, Technology Tagged With: FDA, Insulet

FDA approves next-gen intrathecal drug delivery system from Medtronic

October 10, 2023 By Sean Whooley

Medtronic SynchroMed III drug delivery system

Medtronic (NYSE:MDT) announced today that the FDA approved its next-generation SynchroMed III intrathecal drug delivery system. The medtech giant designed SynchroMed III to treat patients with chronic pain, cancer pain and severe spasticity. The targeted drug delivery (TDD) system alleviates symptoms by delivering medication directly to the fluid surrounding the spinal cord. SynchroMed III builds upon […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pain Management, Regulatory/Compliance Tagged With: FDA, Medtronic

FDA approves wearable injector from Enable Injections

October 2, 2023 By Sean Whooley

Enable Injections enFuse Empaveli Injector

Enable Injections announced today that it received FDA approval for its enFuse injector for the delivery of Empaveli. Empaveli, commercialized by Apellis Pharmaceuticals, treats adults with paroxysmal nocturnal hemoglobinuria (PNH). The injector — in this case, called the Empaveli Injector — offers self-administration of the pharmaceutical. The compact, wearable device streamlines the self-administration experience with […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pharmaceuticals, Regulatory/Compliance Tagged With: Apellis Pharmaceuticals, Enable Injections, FDA

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Interim pages omitted …
  • Page 99
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS